RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

Table 1 Patients, tissue samples and cell lines

Patient	Original tissue	Histopathological classification	Cell line	Former name
1	P1	PAC	TihoDProAdcarc1258	CT1258
2	P2	PAC	TihoDProAdcarc0846	DT08/46
3	P3	PAC	TihoDProAdcarc1508	DT15/08
4	P4.1^a	PAC	TihoDProAdcarc1511.1	none
	Ln4.2	PAC metastasis	TihoDProMetadcarc1511.2	none
	Ln4.3	PAC metastasis	TihoDProMetadcarc1511.3	none
5	n.a	TCC^b	TihoDProCarc/TCC0840	DT08/40
6	P6.1	TCC	TihoDProTCC1509	DT15/09
6	Ln6.2	TCC metastasis	None
7	B7	TCC	TihoDUrtTCC1506	DT15/06
8	B8	TCC	None
9	B9	TCC	None
10	B10	TCC	None

Original tissue (P, Prostate; B, urinary bladder; Ln, lymph node); cell lines’ names are explained as institution (Tiho, University of Veterinary Medicine Hannover); species (D, dog); tissue origin (Pro, prostate; Urt, urinary tract (urinary bladder)); diagnosis (Adcarc, adenocarcinoma; Carc, carcinoma; Metadcarc, metastasis of an adenocarcinoma); abbreviations of cell lines written in bold; none, cell lines have not been published yet; n.a., cell line was established from leftover cells from diagnostic fine needle aspiration biopsy, as the patient owners declined surgery and necropsy; ^aRNA quality not sufficient; ^bdiagnosis by cytology of cells obtained by fine needle aspiration biopsy; former name: cell lines were previously published under different names [43, 44]

ISSN: 1475-2867